183 related articles for article (PubMed ID: 38421899)
21. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
Dias LM; Sharifi F; de Keijzer MJ; Mesquita B; Desclos E; Kochan JA; de Klerk DJ; Ernst D; de Haan LR; Franchi LP; van Wijk AC; Scutigliani EM; Cavaco JEB; Tedesco AC; Huang X; Pan W; Ding B; Krawczyk PM; Heger M;
J Photochem Photobiol B; 2021 Mar; 216():112146. PubMed ID: 33601256
[TBL] [Abstract][Full Text] [Related]
22. Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model.
Goff BA; Hermanto U; Rumbaugh J; Blake J; Bamberg M; Hasan T
Br J Cancer; 1994 Sep; 70(3):474-80. PubMed ID: 8080733
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy: a review.
McCaughan JS
Drugs Aging; 1999 Jul; 15(1):49-68. PubMed ID: 10459732
[TBL] [Abstract][Full Text] [Related]
24. Vascular-targeted photodynamic therapy with glucose-conjugated chlorin e6 for dogs with spontaneously occurring tumours.
Osaki T; Hibino S; Murahata Y; Amaha T; Yokoe I; Yamashita M; Nomoto A; Yano S; Tanaka M; Kataoka H; Okamoto Y
Vet Med Sci; 2023 Nov; 9(6):2534-2541. PubMed ID: 37715623
[TBL] [Abstract][Full Text] [Related]
25. Porphyrin-lipid nanovesicles (Porphysomes) are effective photosensitizers for photodynamic therapy.
Guidolin K; Ding L; Chen J; Wilson BC; Zheng G
Nanophotonics; 2021 Sep; 10(12):3161-3168. PubMed ID: 36405498
[TBL] [Abstract][Full Text] [Related]
26. EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
van Driel PBAA; Boonstra MC; Slooter MD; Heukers R; Stammes MA; Snoeks TJA; de Bruijn HS; van Diest PJ; Vahrmeijer AL; van Bergen En Henegouwen PMP; van de Velde CJH; Löwik CWGM; Robinson DJ; Oliveira S
J Control Release; 2016 May; 229():93-105. PubMed ID: 26988602
[TBL] [Abstract][Full Text] [Related]
27. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
28. A review of nanoparticle photosensitizer drug delivery uptake systems for photodynamic treatment of lung cancer.
Mokwena MG; Kruger CA; Ivan MT; Heidi A
Photodiagnosis Photodyn Ther; 2018 Jun; 22():147-154. PubMed ID: 29588217
[TBL] [Abstract][Full Text] [Related]
29. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.
de Bruijn HS; Mashayekhi V; Schreurs TJL; van Driel PBAA; Strijkers GJ; van Diest PJ; Lowik CWGM; Seynhaeve ALB; Hagen TLMT; Prompers JJ; Henegouwen PMPVBE; Robinson DJ; Oliveira S
Theranostics; 2020; 10(5):2436-2452. PubMed ID: 32089747
[TBL] [Abstract][Full Text] [Related]
30. Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma.
Wu Q; Ning H; Wang H; Hua H; Li W; Xu B
J Drug Target; 2023 Jun; 31(5):511-520. PubMed ID: 37000919
[TBL] [Abstract][Full Text] [Related]
31. Clinical PDT dose dosimetry for pleural Photofrin-mediated photodynamic therapy.
Sun H; Ong Y; Yang W; Sourvanos D; Dimofte A; Busch TM; Singhal S; Cengel KA; Zhu TC
J Biomed Opt; 2024 Jan; 29(1):018001. PubMed ID: 38223299
[TBL] [Abstract][Full Text] [Related]
32. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas.
Cincotta L; Foley JW; MacEachern T; Lampros E; Cincotta AH
Cancer Res; 1994 Mar; 54(5):1249-58. PubMed ID: 8118813
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy.
Kawaguchi T; Yamamoto S; Naka N; Okishio K; Atagi S; Ogawara M; Hosoe S; Kawahara M; Furuse K
Br J Cancer; 2000 Jan; 82(2):418-23. PubMed ID: 10646898
[TBL] [Abstract][Full Text] [Related]
34. Role of apoptosis in photodynamic sensitivity of human tumour cell lines.
Gupta S; Dwarakanath BS; Muralidhar K; Jain V
Indian J Exp Biol; 2003 Jan; 41(1):33-40. PubMed ID: 15267133
[TBL] [Abstract][Full Text] [Related]
35. Zinc phthalocyanine loaded- antibody functionalized nanoparticles enhance photodynamic therapy in monolayer (2-D) and multicellular tumour spheroid (3-D) cell cultures.
Simelane NWN; Abrahamse H
Front Mol Biosci; 2023; 10():1340212. PubMed ID: 38259685
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy and diagnosis: Principles and comparative aspects.
Dobson J; de Queiroz GF; Golding JP
Vet J; 2018 Mar; 233():8-18. PubMed ID: 29486883
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
Andrejevic-Blant S; Hadjur C; Ballini JP; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
Br J Cancer; 1997; 76(8):1021-8. PubMed ID: 9376261
[TBL] [Abstract][Full Text] [Related]
38. Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model.
Goff BA; Blake J; Bamberg MP; Hasan T
Br J Cancer; 1996 Oct; 74(8):1194-8. PubMed ID: 8883404
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcome of Photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia.
Ikeda H; Tobita T; Ohba S; Uehara M; Asahina I
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):229-35. PubMed ID: 23993848
[TBL] [Abstract][Full Text] [Related]
40. 5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.
Wachowska M; Gabrysiak M; Muchowicz A; Bednarek W; Barankiewicz J; Rygiel T; Boon L; Mroz P; Hamblin MR; Golab J
Eur J Cancer; 2014 May; 50(7):1370-81. PubMed ID: 24559534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
